The heady days of computed tomography (CT) — when 64-slice scanners drove sales to an all-time high — seems like ancient history. Hard to believe it was less than 10 years ago. Since then demand has fallen. The installed base, predictably, has grown old.

It used to be that once every four to five years, providers would turn out their old CTs in favor of new ones. Lately they have been holding on. The average lifespan of individual systems has grown, in some cases to eight, nine, even 10 years. And it could get longer.

Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing installed base of competing systems. The premier European comprehensive cancer center started its radiotherapy program in 2013.

TRU-Vu Monitors has launched a new line of 24-inch HD surgical LCD monitors and touch screens.

MMZBTP-24 Series surgical touch screens

Women who are carriers of mutated BRCA genes are known to have a significantly higher risk for developing breast and ovarian cancers than those who don't have the mutations. But a new study by the University of California Los Angeles (UCLA) faculty questions the value of screening for the genetic mutations in the general population — including those who do not have cancer or have no family history of the disease — because of the high cost.

Despite numerous major changes looming in the healthcare industry, the 2015 edition of the Great American Physician Survey found that U.S. physicians are still happy in their careers.

School-age children born prematurely are more likely to have low mathematical achievement, thought to be associated with reduced working memory and number skills, according to a study in the neurology journal Brain.

Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business Innovation Research (SBIR) grant up to $1.8 million from the National Cancer Institute (NCI), National Institutes of Health (NIH). The grant will be used to fund preclinical studies examining the safety of intravenous (IV) injection of Tc99m tilmanocept, a Manocept platform product.

Eizo Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis on its 5-megapixel monochrome medical monitor, the RadiForce GX540.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now